FDA Warnings Slow, But Anti-Aging Claims Remain Class Action Targets
This article was originally published in The Rose Sheet
Executive Summary
The online universe is abuzz with complaints about 2016, with some ready to dub the year “worst ever.” It certainly was a rough one for anti-aging skin-care marketers, and while FDA’s warning letter activity has declined of late, consumer lawsuits continue to file challenging companies’ clock-reversing promises.